Stocks
Funds
Screener
Sectors
Watchlists

Latest Saturn V Capital Management LLC Stock Portfolio

Saturn V Capital Management LLC Performance:
2024 Q3: 6.31%YTD: 9.41%2023: 14%

Performance for 2024 Q3 is 6.31%, and YTD is 9.41%, and 2023 is 14%.

About Saturn V Capital Management LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Saturn V Capital Management LP reported an equity portfolio of $279.8 Millions as of 30 Sep, 2024.

The top stock holdings of Saturn V Capital Management LP are , , PCVX. The fund has invested 10.7% of it's portfolio in ASCENDIS PHARMA A/S and 9% of portfolio in DISC MEDICINE INC.

The fund managers got completely rid off AMICUS THERAPEUTICS INC (FOLD), ANAPTYSBIO INC (ANAB) and ENLIVEN THERAPEUTICS INC stocks. They significantly reduced their stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), CRINETICS PHARMACEUTICALS IN (CRNX) and ARGENX SE. Saturn V Capital Management LP opened new stock positions in CG ONCOLOGY INC and MOONLAKE IMMUNOTHERAPEUTICS (MLTX). The fund showed a lot of confidence in some stocks as they added substantially to ASCENDIS PHARMA A/S, PHATHOM PHARMACEUTICALS INC (PHAT) and CELCUITY INC (CELC).

Saturn V Capital Management LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Saturn V Capital Management LP made a return of 6.31% in the last quarter. In trailing 12 months, it's portfolio return was 27.12%.

New Buys

Ticker$ Bought
cg oncology inc19,624,100
moonlake immunotherapeutics15,074,300
silence therapeutics plc8,746,890
arrivent biopharma inc1,110,750

New stocks bought by Saturn V Capital Management LLC

Additions

Ticker% Inc.
ascendis pharma a/s76.89
phathom pharmaceuticals inc47.41
celcuity inc24.36
cytokinetics inc21.78
inozyme pharma inc20.04
syndax pharmaceuticals inc19.62
cargo therapeutics inc16.99
neumora therapeutics inc.11.00

Additions to existing portfolio by Saturn V Capital Management LLC

Reductions

Ticker% Reduced
biomarin pharmaceutical inc-79.04
crinetics pharmaceuticals in-77.16
argenx se-65.56
longboard pharmaceuticals in-55.87
kalvista pharmaceuticals inc-50.69
iteos therapeutics inc-46.74
merus n v-20.35
vaxcyte inc-4.96

Saturn V Capital Management LLC reduced stake in above stock

Sold off

Ticker$ Sold
amicus therapeutics inc-7,078,280
anaptysbio inc-6,255,200
enliven therapeutics inc-3,556,400
rapport therapeutics inc-1,628,200
morphic hldg inc-1,623,780

Saturn V Capital Management LLC got rid off the above stocks

Sector Distribution

Saturn V Capital Management LP has about 53.7% of it's holdings in Healthcare sector.

Sector%
Healthcare53.7
Others46.3

Market Cap. Distribution

Saturn V Capital Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED46.3
SMALL-CAP28.4
MID-CAP24.4

Stocks belong to which Index?

About 45% of the stocks held by Saturn V Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others55
RUSSELL 200045
Top 5 Winners (%)%
PHAT
phathom pharmaceuticals inc
64.5 %
PCVX
vaxcyte inc
49.2 %
COGT
cogent biosciences inc
27.7 %
LBPH
longboard pharmaceuticals in
26.4 %
CRNX
crinetics pharmaceuticals in
16.8 %
Top 5 Winners ($)$
PCVX
vaxcyte inc
8.0 M
PHAT
phathom pharmaceuticals inc
6.2 M
COGT
cogent biosciences inc
4.0 M
CRNX
crinetics pharmaceuticals in
3.6 M
MLTX
moonlake immunotherapeutics
1.2 M
Top 5 Losers (%)%
IRWD
ironwood pharmaceuticals inc
-36.7 %
MRUS
merus n v
-15.0 %
ITOS
iteos therapeutics inc
-13.8 %
CELC
celcuity inc
-9.1 %
SNDX
syndax pharmaceuticals inc
-6.2 %
Top 5 Losers ($)$
IRWD
ironwood pharmaceuticals inc
-2.7 M
MRUS
merus n v
-1.5 M
CELC
celcuity inc
-1.4 M
ITOS
iteos therapeutics inc
-0.8 M
SNDX
syndax pharmaceuticals inc
-0.6 M

Saturn V Capital Management LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Saturn V Capital Management LLC

Saturn V Capital Management LP has 25 stocks in it's portfolio. About 70.6% of the portfolio is in top 10 stocks. IRWD proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for Saturn V Capital Management LP last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions